Breast Biopsy Market Overview
A breast biopsy is a simple medical procedure in which a sample of breast tissue is removed and sent to a laboratory for testing. A breast biopsy is the best way to evaluate if a suspicious lump or portion of the breast is cancerous.
The increasing incidences of breast cancer across the world and growing awareness about this disease and treatment, are the most prominent factors escalating the growth of the global Breast Biopsy market. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
Furthermore, other factors include a higher incidence of breast cancer among postmenopausal women. Therefore, countries, where there are higher proportions of women above 40 age group, would be potential markets for breast cancer screening and diagnosis. In addition, new product approvals and launches coupled with growing inclination towards minimally invasive and image-guided needle biopsies such as vacuum-assisted biopsy and core needle biopsy are responsible for the substantial growth of the global Breast Biopsy market during the forecast period.
On the downside, the high cost of the procedure, infection risks associated with breast biopsy procedures, uncertain regulatory issues, and unclear reimbursement policies are the factors hampering the growth of the market.
COVID-19 Impact on Breast Biopsy Market
In addition, the current Breast Biopsy Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Breast Biopsy Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Breast Biopsy Market Segment Overview
According to Product, Core Needle Biopsy (CNB) segment dominated the global Breast Biopsy market and is expected to maintain this trend throughout the forecast period. This is due to the less invasive procedure compared to others and it provides a more definitive diagnosis. Additionally, the use of CNB and ultrasonographic and mammographic guidance is highly accurate for diagnosing breast cancer that increases the growth of the market. Furthermore, by Guided Technology, the Ultrasound Guided Biopsy segment is expected to grow at the highest rate during the forecast period. This is due to the sound waves used instead of ionizing radiation to locate abnormality or lump and is less invasive with reduced scars.
Breast Biopsy Market, By Product
· Vacuum Assisted Biopsy (VAB)
· Core Needle Biopsy (CNB)
· Fine Needle Aspiration Biopsy (FNAB)
Breast Biopsy Market, By Guided Technology
· MRI-Guided Biopsy
· Ultrasound Guided Biopsy
· Mammography Guided Stereotactic Biopsy
· CT-Guided Biopsy
· Others
Breast Biopsy Market, By End User
· Hospitals
· Ambulatory Surgical Centers & Clinics
Breast Biopsy Market Regional Overview
Geographically, the Asia Pacific region is expected to witness the highest growth in the Breast Biopsy market during the forecast period. The healthcare infrastructure in developing countries such as China, India, and South Korea is evolving at a rapid pace, leading to major investments in advanced systems including liquid breast biopsy, and vacuum-assisted biopsy instruments, among others by hospitals and breast care centers. This factor is boosting the growth of the Asia pacific breast biopsy market. Additionally, the growing prevalence of breast cancer, the increasing number of awareness programs for the early detection of breast cancer, and the huge government spending on breast cancer research studies are the other major factors that propelling the growth of the breast biopsy market in Asia Pacific region.
Breast Biopsy Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Breast Biopsy Market, Key Players
· Biomed Diagnostics, Inc.
· Bard Peripheral Vascular Inc.
· F. Hoffmann-La Roche Ltd.
· Hologic Inc.
· Intact Medical
· Mammotome
· OncoCyte Corporation
· Laboratory Corporation of America Holdings (Labcorp)
List of Figures
Figure 1: Global Breast Biopsy Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Breast Biopsy Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Breast Biopsy Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Breast Biopsy Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Breast Biopsy Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Breast Biopsy Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Breast Biopsy Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Breast Biopsy Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Breast Biopsy Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Breast Biopsy Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Breast Biopsy Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Breast Biopsy Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Breast Biopsy Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Breast Biopsy Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Breast Biopsy Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Breast Biopsy Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Breast Biopsy Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Breast Biopsy Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Breast Biopsy Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Breast Biopsy Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Breast Biopsy Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Breast Biopsy Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Breast Biopsy Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Breast Biopsy Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Breast Biopsy Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Breast Biopsy Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
